Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Host-related carcinoembryonic antigen cell adhesion molecule 1 promotes metastasis of colorectal cancer

Abstract

Liver metastasis is the predominant cause of colorectal cancer (CRC)-related mortality in developed countries. Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is a cell adhesion molecule with reduced expression in early phases of CRC development and thus functions as a tumor growth inhibitor. However, CEACAM1 is upregulated in metastatic colon cancer, suggesting a bimodal role in CRC progression. To investigate the role of this protein in the host metastatic environment, Ceacam1−/− mice were injected intrasplenically with metastatic MC38 mouse CRC cells. A significant reduction in metastatic burden was observed in Ceacam1−/− compared with wild-type (WT) livers. Intravital microscopy showed decreased early survival of MC38 cells in Ceacam1−/− endothelial environment. Metastatic cell proliferation within the Ceacam1−/− livers was also diminished. Bone marrow-derived cell recruitment, attenuation of immune infiltrates and diminished CCL2, CCL3 and CCL5 chemokine production participated in the reduced Ceacam1−/− metastatic phenotype. Transplantations of WT bone marrow (BM) into Ceacam1−/− mice fully rescued metastatic development, whereas Ceacam1−/− BM transfer into WT mice showed reduced metastatic burden. Chimeric immune cell profiling revealed diminished recruitment of CD11b+Gr1+ myeloid-derived suppressor cells (MDSCs) to Ceacam1−/− metastatic livers and adoptive transfer of MDSCs confirmed the involvement of these immune cells in reduction of liver metastasis. CEACAM1 may represent a novel metastatic CRC target for treatment.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Bamberger AM, Riethdorf L, Nollau P, Naumann M, Erdmann I, Gotze J et al. (1998). Dysregulated expression of CD66a (BGP, C-CAM), an adhesion molecule of the CEA family, in endometrial cancer. Am J Pathol 152: 1401–1406.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Beauchemin N, Draber P, Dveksler G, Gold P, Gray-Owen S, Grunert F et al. (1999). Redefined nomenclature for members of the carcinoembryonic antigen family. Exp Cell Res 252: 243–249.

    Article  CAS  PubMed  Google Scholar 

  • Busch C, Hanssen TA, Wagener C, Obrink B . (2002). Down-regulation of CEACAM1 in human prostate cancer: correlation with loss of cell polarity, increased proliferation rate, and Gleason grade 3 to 4 transition. Hum Pathol 33: 290–298.

    Article  CAS  PubMed  Google Scholar 

  • Chen T, Zimmermann W, Parker J, Chen I, Maeda A, Bolland S . (2001). Biliary glycoprotein (BGPa, CD66a, CEACAM1) mediates inhibitory signals. J Leukoc Biol 70: 335–340.

    CAS  PubMed  Google Scholar 

  • Chen Z, Chen L, Baker K, Olszak T, Zeissig S, Huang YH et al. (2011). CEACAM1 dampens anti-tumor immunity by downregulation of NKG2D ligand expression on tumor cells and NKG2D function on NK cells. J Exp Med 208: 2633–2640.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dango S, Sienel W, Schreiber M, Stremmel C, Kirschbaum A, Pantel K et al. (2008). Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM-1) is associated with increased angiogenic potential in non-small-cell lung cancer. Lung Cancer 60: 426–433.

    Article  PubMed  Google Scholar 

  • Ebrahimnejad A, Streichert T, Nollau P, Horst AK, Wagener C, Bamberger AM et al. (2004). CEACAM1 enhances invasion and migration of melanocytic and melanoma cells. Am J Pathol 165: 1781–1787.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gabrilovich DI, Nagaraj S . (2009). Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9: 162–174.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Giavazzi R, Campbell DE, Jessup JM, Cleary K, Fidler IJ . (1986). Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice. Cancer Res 46: 1928–1933.

    CAS  PubMed  Google Scholar 

  • Gout S, Huot J . (2008). Role of cancer microenvironment in metastasis: focus on colon cancer. Cancer Microenviron 1: 69–83.

    Article  PubMed  PubMed Central  Google Scholar 

  • Gray-Owen SD, Blumberg RS . (2006). CEACAM1: contact-dependent control of immunity. Nat Rev Immunol 6: 433–446.

    Article  CAS  PubMed  Google Scholar 

  • Hanahan D, Weinberg RA . (2011). Hallmarks of cancer: the next generation. Cell 144: 646–674.

    Article  CAS  PubMed  Google Scholar 

  • Hemmila E, Turbide C, Olson M, Jothy S, Holmes KV, Beauchemin N . (2004). Ceacam1a-/- mice are completely resistant to infection by murine coronavirus MHV-A59. J Virol 78: 10156–10165.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Horst A, Bickert T, Brewig N, Schumacher U, Beauchemin N, Fleischer B et al. (2009). CEACAM1 expression on macrophage precursors affects early lymphangiogenesis in vivo. Blood 113: 6726–6736.

    Article  CAS  PubMed  Google Scholar 

  • Horst AK, Wulf DI, Dabelstein J, Schumacher U, Sander H, Turbide C et al. (2006). Carcinoembryonic antigen-related cell adhesion molecule 1 modulates vascular remodeling in vitro and in vivo. J Clin Investig 116: 1596–1605.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ieda J, Yokoyama S, Tamura K, Takifuji K, Hotta T, Matsuda K et al. (2011). Re-expression of CEACAM1 long cytoplasmic domain isoform is associated with invasion and migration of colorectal cancer. Int J Cancer 129: 1351–1361.

    Article  CAS  PubMed  Google Scholar 

  • Kang WY, Chen WT, Wu MT, Chai CY . (2007). Expression of CD66a and possible roles in colorectal adenoma and adenocarcinoma. Int J Colorectal Dis 22: 869–874.

    Article  PubMed  Google Scholar 

  • Kaplan RN, Rafii S, Lyden D . (2006). Preparing the “soil”: the premetastatic niche. Cancer Res 66: 11089–11093.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kirshner J, Chen CJ, Liu P, Huang J, Shively JE . (2003). CEACAM1-4S, a cell-cell adhesion molecule, mediates apoptosis and reverts mammary carcinoma cells to a normal morphogenic phenotype in a 3D culture. Proc Natl Acad Sci USA 100: 521–526.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Laurie NA, Comegys MM, Carreiro MP, Brown JF, Flanagan DL, Brilliant KE et al. (2005). Carcinoembryonic antigen-related cell adhesion molecule 1a-4L suppression of rat hepatocellular carcinomas. Cancer Res 65: 11010–11017.

    Article  CAS  PubMed  Google Scholar 

  • Leung N, Turbide C, Balachandra B, Marcus V, Beauchemin N . (2008). Intestinal tumor progression is promoted by decreased apoptosis and dysregulated Wnt signaling in Ceacam1(-/-) mice. Oncogene 27: 4943–4953.

    Article  CAS  PubMed  Google Scholar 

  • Leung N, Turbide C, Marcus V, Jothy S, Beauchemin N . (2006). Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) contributes to progression of colon tumors. Oncogene 25: 5527–5536.

    Article  CAS  PubMed  Google Scholar 

  • Liu W, Wei W, Winer D, Bamberger AM, Bamberger C, Wagener C et al. (2007). CEACAM1 impedes thyroid cancer growth but promotes invasiveness: a putative mechanism for early metastases. Oncogene 26: 2747–2758.

    Article  PubMed  Google Scholar 

  • Loberg RD, Ying C, Craig M, Day LL, Sargent E, Neeley C et al. (2007). Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo. Cancer Res 67: 9417–9424.

    Article  CAS  PubMed  Google Scholar 

  • Ma G, Pan PY, Eisenstein S, Divino CM, Lowell CA, Takai T et al. (2011). Paired-immunoglobulin-like receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells. Immunity 34: 385–395.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Movahedi K, Guilliams M, Van den Bossche J, Van den Bergh R, Gysemans C, Beschin A et al. (2008). Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 111: 4233–4244.

    Article  CAS  PubMed  Google Scholar 

  • Nagaishi T, Pao L, Lin SH, Iijima H, Kaser A, Qiao SW et al. (2006). SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. Immunity 25: 769–781.

    Article  CAS  PubMed  Google Scholar 

  • Neumaier M, Paululat S, Chan A, Matthaes P, Wagener C . (1993). Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas. Proc Natl Acad Sci USA 90: 10744–10748.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nittka S, Gunther J, Ebisch C, Erbersdobler A, Neumaier M . (2004). The human tumor suppressor CEACAM1 modulates apoptosis and is implicated in early colorectal tumorigenesis. Oncogene 23: 9306–9313.

    Article  CAS  PubMed  Google Scholar 

  • Niwa Y, Akamatsu H, Niwa H, Sumi H, Ozaki Y, Abe A . (2001). Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. Clin Cancer Res 7: 285–289.

    CAS  PubMed  Google Scholar 

  • Nollau P, Prall F, Helmchen U, Wagener C, Neumaier M . (1997). Dysregulation of carcinoembryonic antigen group members CGM2, CD66a (biliary glycoprotein), and nonspecific cross-reacting antigen in colorectal carcinomas. Comparative analysis by northern blot and in situ hybridization. Am J Pathol 151: 521–530.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Nouvion AL, Oubaha M, LeBlanc S, Davis EC, Jastrow H, Kammerer R et al. (2010). CEACAM1: a key regulator of vascular permeability. J Cell Sci 123: 4221–4230.

    Article  CAS  PubMed  Google Scholar 

  • Obrink B . (2008). On the role of CEACAM1 in cancer. Lung Cancer 60: 309–312.

    Article  PubMed  Google Scholar 

  • Oliveira-Ferrer L, Tilki D, Ziegeler G, Hauschild J, Loges S, Irmak S et al. (2004). Dual role of carcinoembryonic antigen-related cell adhesion molecule 1 in angiogenesis and invasion of human urinary bladder cancer. Cancer Res 64: 8932–8938.

    Article  CAS  PubMed  Google Scholar 

  • Pan H, Shively JE . (2010). Carcinoembryonic antigen-related cell adhesion molecule-1 regulates granulopoiesis by inhibition of granulocyte colony-stimulating factor receptor. Immunity 33: 620–631.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Popivanova BK, Kostadinova FI, Furuichi K, Shamekh MM, Kondo T, Wada T et al. (2009). Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice. Cancer Res 69: 7884–7892.

    Article  CAS  PubMed  Google Scholar 

  • Poy MN, Yang Y, Rezaei K, Fernstrom MA, Lee AD, Kido Y et al. (2002). CEACAM1 regulates insulin clearance in liver. Nat Genet 30: 270–276.

    Article  PubMed  Google Scholar 

  • Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR et al. (2011). CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475: 222–225.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rosenberg M, Nédellec P, Jothy S, Fleiszer D, Turbide C, Beauchemin N . (1993). The expression of mouse biliary glycoprotein, a carcinoembryonic antigen-related gene, is down-regulated in malignant mouse tissues. Cancer Res 53: 4938–4945.

    CAS  PubMed  Google Scholar 

  • Serra S, Asa SL, Bamberger AM, Wagener C, Chetty R . (2009). CEACAM1 expression in pancreatic endocrine tumors. Appl Immunohistochem Mol Morphol 17: 286–293.

    Article  CAS  PubMed  Google Scholar 

  • Skalli O, Pelte MF, Peclet MC, Gabbiani G, Gugliotta P, Bussolati G et al. (1989). Alpha-smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes. J Histochem Cytochem 37: 315–321.

    Article  CAS  PubMed  Google Scholar 

  • Song JH, Cao Z, Yoon JH, Nam SW, Kim SY, Lee JY et al. (2011). Genetic alterations and expression pattern of CEACAM1 in colorectal adenomas and cancers. Pathol Oncol Res 17: 67–74.

    Article  CAS  PubMed  Google Scholar 

  • Starke RD, Ferraro F, Paschalaki KE, Dryden NH, McKinnon TA, Sutton RE et al. (2011). Endothelial von Willebrand factor regulates angiogenesis. Blood 117: 1071–1080.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wu Y, Brodt P, Sun H, Mejia W, Novosyadlyy R, Nunez N et al. (2010). Insulin-like growth factor-I regulates the liver microenvironment in obese mice and promotes liver metastasis. Cancer Res 70: 57–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Xu E, Leung N, Dubois MJ, Charbonneau A, Streichert T, Elcheby M et al. (2009). Targeted disruption of Ceacam1 promotes diet-induced hepatic steatosis and insulin resistance. Endocrinol 150: 3503–3512.

    Article  CAS  Google Scholar 

  • Yeatman TJ, Mao W, Karl RC . (1997). Biliary glycoprotein is overexpressed in human colon cancer cells with high metastatic potential. J Gastrointest Surg 1: 292–298.

    Article  CAS  PubMed  Google Scholar 

  • Yoshidome H, Kohno H, Shida T, Kimura F, Shimizu H, Ohtsuka M et al. (2009). Significance of monocyte chemoattractant protein-1 in angiogenesis and survival in colorectal liver metastases. Int J Oncol 34: 923–930.

    Article  CAS  PubMed  Google Scholar 

  • Zhou CJ, Liu B, Zhu KK, Zhang QH, Zhang TG, Xu WH et al. (2009). The different expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) and possible roles in gastric carcinomas. Pathol Res Pract 205: 483–489.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We wish to thank Drs Janusz Rak, Peter Siegel and Julie St-Pierre (McGill University) for their helpful corrections and comments on the manuscript. We are also indebted to Dr Russell Jones (McGill University) for help with bone marrow transplantations and Dr Kathryn V Holmes (University of Colorado) for the monoclonal CC1 antibody. This work was supported by grants from the Canadian Institutes for Health Research (NB, LF and PB) and the Canadian Cancer Society Research Institute (LF). AA and ALN were recipients of post-doctoral fellowships from the Fonds de la Recherche en Santé du Québec (FRSQ). AA and CC received post-doctoral awards from the McGill Integrated Cancer Research Training Program funded by the Canadian Institutes for Health Research and the Fonds de la Recherche en Santé du Québec (FRSQ).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N Beauchemin.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Oncogene website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arabzadeh, A., Chan, C., Nouvion, AL. et al. Host-related carcinoembryonic antigen cell adhesion molecule 1 promotes metastasis of colorectal cancer. Oncogene 32, 849–860 (2013). https://doi.org/10.1038/onc.2012.112

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2012.112

Keywords

This article is cited by

Search

Quick links